Preferred Label : Pathologic Stage IIIC Cutaneous Melanoma AJCC v8;
NCIt synonyms : Pathologic Stage IIIC Melanoma of the Skin AJCC v8;
NCIt related terms : Stage IIIC Cutaneous (Skin) Melanoma; Stage IIIC;
NCIt definition : Stage IIIC includes: (T0, N2b, N2c, N3b or N3c); (T1a-T3a, N2c or N3a/b/c, M0); (T3b/T4a,
Any N greater than or equal to N1, M0); (T4b, N1a-N2c, M0). T0: No evidence of primary
tumor (e.g., unknown primary or completely regressed melanoma). Thickness: Not applicable.
Ulceration status: Not applicable. T1a: Tumor measuring less than 0.8 mm in thickness.
Ulceration status: Without ulceration. T1b: Tumor measuring less than 0.8 mm in thickness
with ulceration, or 0.8-1.0 mm with or without ulceration. T2a: Tumor measuring more
than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: Without
ulceration. T2b: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in
thickness. Ulceration status: With ulceration. T3a: Tumor measuring more than 2.0
and equal to or less than 4.0 mm in thickness. Ulceration status: Without ulceration.
T3b: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness.
Ulceration status: With ulceration. T4a: Tumor measuring more than 4.0 mm in thickness.
Ulceration status: Without ulceration. T4b: Tumor measuring more than 4.0 mm in thickness.
Ulceration status: With ulceration. N2b: Two or three nodal metastases at least one
of which was clinically detected. Presence of in-transit, satellite, and/or microsatellite
metastases: No. N2c: One clinically occult nodal metastasis. Presence of in-transit,
satellite, and/or microsatellite metastases: Yes. N3b: Four or more nodal metastases,
at least one of which was clinically detected, or presence of any number of matted
nodes. Presence of in-transit, satellite, and/or microsatellite metastases: No. N3c:
Two or more clinically occult nodal metastases. Presence of in-transit, satellite,
and/or microsatellite metastases: Yes. N3a: Four or more clinically occult nodal metastasis
(i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite,
and/or microsatellite metastases: No. N1a: One clinically occult nodal metastasis
(i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite,
and/or microsatellite metastases: No. N1b: One clinically detected nodal metastasis.
Presence of in-transit, satellite, and/or microsatellite metastases: No. N1c: No regional
lymph node disease. Presence of in-transit, satellite, and/or microsatellite metastases:
Yes. N2a: Two or three clinically occult nodal metastases (i.e., detected by sentinel
lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases:
No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th
ed.);
Neoplastic status : Malignant;
NCI Metathesaurus CUI : CL524829;
Origin ID : C137673;
UMLS CUI : C4527187;
- Disease may have findings
- Has associated anatomic sites
- See also inter- (CISMeF)
- Semantic type(s)
- concept_is_in_subset
- disease_excludes_finding
- disease_has_abnormal_cell
- disease_has_finding
- disease_has_normal_cell_origin
- disease_has_normal_tissue_origin
- disease_has_primary_anatomic_site
- disease_is_stage